CANCER – RE-STEM BIOTECH

Terms

ABOUT US
TECHNOLOGY
NEWSROOM
INVESTOR
CONTACT

CANCER

RE-AGN 2.0 is a proprietary immuno-oncology therapy being developed to address lung and liver cancers.

Post navigation

Previous Previous post: OSTEOARTHRITIS (OA)

Next Next post: SPINAL CORD INJURY

Recent Posts

Re-Stem Biotech Awarded 2020 Ernst & Young Fudan “China’s Most Promising Company” Award
Re-Stem-Funded Study Targeting Mitochondrial Dysfunction in Aging and Age-Related Diseases Published in Science Advances Journal
Re-Stem Biotech Provides Banking of Immune Cells for Medical Staff in Hubei

Archives

October 2020
August 2020
February 2020
December 2019
November 2019
September 2019
August 2019
May 2019
April 2019
February 2019

RE-Stem 2023 | All Rights Reserved. Design & Developed by Themesglance